(MENAFN- IMARC Group)
The latest report by IMARC Group, titled“ Transfection Technologies market Report by Product Type (Reagent, Instrument, and Others), Application (Therapeutic Delivery, Bio-Medical Research, Protein Production, and Others), Transfection Method (Lipofection, Eletroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, and Others), technology (Physical Transfection, Biochemical Based Transfection, Viral-Vector Based Transfection), End-User (Research Centers and Academic Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Others), and Region 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on the transfection technologies market report . The global market
size reached US$ 1,172.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,275.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
Factors Affecting the Growth of the Transfection Technologies Industry:
Rising Demand in Biopharmaceuticals:
The global rise in demand for biopharmaceuticals, including therapeutic proteins and vaccines, is a significant factor propelling the transfection technologies market. Biopharmaceuticals require the use of living cells in their production process, where transfection technologies play a critical role in the introduction of recombinant DNA to produce the desired proteins. The ongoing COVID-19 pandemic has further accelerated vaccine research and development, highlighting the need for rapid, scalable, and efficient transfection methods. Companies are investing in developing robust transfection protocols to meet the high-volume production requirements of vaccines and therapeutic proteins, aiming to enhance yield and purity. This demand for biopharmaceuticals is driving the growth of the transfection technologies market and also spurring innovations to optimize transfection processes for large-scale manufacturing.
Increasing Cell-Based Research:
The shift toward cell-based research and the advent of personalized medicine are significantly contributing to the growth of the transfection technologies market. Transfection is a cornerstone technique in cell-based assays, drug screening, and stem cell research, providing insights into gene function and regulation, cell behavior, and disease mechanisms. Moreover, personalized medicine, which tailors medical treatment to individual characteristics of each patient, relies heavily on genetic analysis and manipulation, where transfection technologies are indispensable. As personalized medicine gains traction, the need for efficient transfection methods to support the development of targeted therapies and diagnostics increases.
Technological Advancements:
The burgeoning field of gene therapy and the expanding research in molecular biology are pivotal drivers for the transfection technologies market. As scientists and researchers delve deeper into the human genome, understanding genetic disorders at the molecular level, there is a growing demand for efficient and reliable transfection technologies. These technologies are essential for introducing foreign nucleic acids into cells, a fundamental step in gene editing, gene expression studies, and the development of novel therapeutics. The advent of CRISPR-Cas9, a revolutionary gene-editing tool, has particularly underscored the importance of effective transfection methods. As a result, the demand for transfection technologies that offer high efficiency, low cytotoxicity, and the ability to transfect a wide range of cell types is escalating, driving innovation and growth in this market segment.
For an in-depth analysis, you can request a sample copy of the report: https://www.imarcgroup.com/transfection-technologies-market/requestsample
Competitive Landscape:
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.
Agilent Technologies Inc. Bio-RAD Laboratories Inc. Lonza Group AG Maxcyte Inc. Mirus Bio LLC Polyplus Transfection Promega Corporation Roche Holding AG Sigma-Aldrich Corporation Thermo Fisher Scientific Inc.
Transfection Technologies Market Report Segmentation:
By Product Type:
Reagent Instrument Others
Reagents represent the leading segment as they are essential components in various transfection methods, including chemical transfection, lipid-mediated transfection, and polymer-based transfection.
By Application:
Therapeutic Delivery Bio-Medical Research Protein Production Others
Bio-medical research holds the largest market share as it uses transfection methods to study gene function, investigate disease mechanisms, develop therapeutic interventions, and screen potential drug candidates.
By Transfection Method:
Lipofection Eletroporation Nucleofection Cotransfection Cationic Lipid Transfection In-Vivo Transfection Others
Electroporation dominates the market as it involves the application of electrical pulses to create transient pores in cell membranes, facilitating the uptake of nucleic acids.
By Technology:
Physical Transfection Biochemical Based Transfection Viral-Vector Based Transfection
Biochemical-based transfection methods hold the largest market share as they offer simplicity, cost-effectiveness, and compatibility with a broad range of cell types.
By End User:
Research Centers and Academic Institutes Hospitals and Clinics Pharmaceutical and Biotechnology Companies Others
Based on the end user, the market has been classified into research centers and academic institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and others.
By Region:
North America (United States, Canada) Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others) Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others) Latin America (Brazil, Mexico, Others) Middle East and Africa
North America's dominance in transfection technologies market is attributed to the presence of leading biotech companies, academic research institutions, and pharmaceutical firms engaged in cutting-edge research and development activities.
Global Transfection Technologies Market Trends:
The emergence of gene editing technologies such as CRISPR/Cas9 has revolutionized the field of transfection. CRISPR-based techniques enable precise and efficient genome editing, offering unprecedented capabilities for gene function studies, disease modeling, and therapeutic applications. The growing adoption of CRISPR-based transfection methods is driving market growth and innovation in the field. Besides, non-viral transfection methods, such as lipid-based and polymer-based delivery systems, are gaining prominence due to their safety, versatility, and ease of use compared to viral vectors. Non-viral delivery systems offer advantages such as reduced immunogenicity, scalability, and the ability to deliver a wide range of nucleic acids, including mRNA, siRNA, and plasmid DNA, driving their adoption in research and clinical applications.
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=2188&flag=C
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email:
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
MENAFN01032024004122016232ID1107922120